OpenExamsFREE PRACTICE — ANY EXAM

Washington Pharmacist — Requirements & Free Practice

US-WA · License preparation

850 free questions · Answer explanations · No signup required

Choose what to practice

Start with an exam below. Your examination requirements depend on your application pathway. View licensing requirements

Combined practice

Choose an exam or combined practice to begin.

Licenses, application pathways and examination requirements

Each license and applicant pathway has its own requirements and exemptions. Choosing practice questions does not determine your eligibility.

Pharmacist License

Washington pharmacist license issued by the Department of Health under RCW 18.64.080 on qualifications set by the Pharmacy Quality Assurance Commission.

Licensing authority: Washington State Pharmacy Quality Assurance Commission (Washington State Department of Health) · Application information

Original license by examination for graduates of a foreign school or college of pharmacy

All of the following:

Age
At least 18 years of age (RCW 18.64.080(1)(a)).
Character
Good moral and professional character and fitness to practice (RCW 18.64.080(1)(b)).
English Proficiency
Passing the required TOEFL iBT (Test of English as a Foreign Language, internet-based test) (WAC 246-945-162(2)(a)(ii)).
Foreign Education
Academic training in pharmacy from an institution in a foreign country; official transcripts or diploma showing a baccalaureate or doctorate of pharmacy degree (WAC 246-945-162(2)(b)); non-English documents must be translated.
Fpgec Certification
Certification by the Foreign Pharmacy Graduate Examination Committee (FPGEC), which includes passing the FPGEE and the required TOEFL iBT (WAC 246-945-162(2)(a)).
Internship
Certification of at least 1,500 pharmacy internship hours earned under the personal supervision of a licensed pharmacist in a licensed U.S. pharmacy (WAC 246-945-162(2)(c); DOH 690-266 item 7).
Jurisprudence Transition
Guidance G010: MPJE passing scores are accepted only if the MPJE was taken on or before December 29, 2026; UMPJE passing scores are accepted if the UMPJE was taken on or after April 1, 2026 (available to Washington applicants from July 2, 2026). MPJE passing scores obtained earlier remain acceptable prior evidence.
Passing Score
A score of 75 or higher on the NAPLEX and the jurisprudence examination (WAC 246-945-165(2)).
Original license by examination for graduates of an ACPE accredited U.S. school or college of pharmacy

All of the following:

Age
At least 18 years of age (RCW 18.64.080(1)(a)).
Character
Good moral and professional character and fitness to practice (RCW 18.64.080(1)(b)).
Early Umpje
Students beginning Advanced Pharmacy Practice Experience may take the UMPJE before graduation after purchasing an NABP eligibility application (Guidance G010).
Education
Baccalaureate degree in pharmacy or doctor of pharmacy degree from a commission-accredited school or college of pharmacy (RCW 18.64.080(1)(c)); official transcripts sent directly from the school.
Exam Authorization
A complete pharmacist application must be submitted and the commission must authorize testing before the NAPLEX (WAC 246-945-165(1); Guidance G010).
Internship
Graduates before July 1, 2020 certify at least 1,500 pharmacy internship hours; PharmD graduates after July 1, 2020 are deemed to meet the practice experience requirement (WAC 246-945-162(1)).
Jurisprudence Transition
Guidance G010: MPJE passing scores are accepted only if the MPJE was taken on or before December 29, 2026; UMPJE passing scores are accepted if the UMPJE was taken on or after April 1, 2026 (available to Washington applicants from July 2, 2026). MPJE passing scores obtained earlier remain acceptable prior evidence.
Passing Score
A score of 75 or higher on each examination (WAC 246-945-165(2)).
Retakes
After three failures of either examination, a commission-approved study or tutorial program is required before further examination (WAC 246-945-165(3)).
Return to active status of a Washington pharmacist license expired for three years or more while actively practicing in another U.S. jurisdiction

At least one of the following alternatives:

  • Uniform MPJE
  • Multistate Pharmacy Jurisprudence Examination for Washington (practice unavailable)
Active Elsewhere
Holds an active credential in good standing in another U.S. jurisdiction, provides certification of that license and verification of current active pharmacy practice (WAC 246-945-173(2)(b)-(c)).
Expired Three Years Or More
The Washington pharmacist license has been expired for three years or more (WAC 246-945-173(2)).
General Requirements
Meets WAC 246-12-040 (abbreviated application, late renewal penalty, current renewal fee, expired credential reissuance fee and declarations) (WAC 246-945-173(2)(a)).
Jurisprudence Transition
Guidance G010: MPJE passing scores are accepted only if the MPJE was taken on or before December 29, 2026; UMPJE passing scores are accepted if the UMPJE was taken on or after April 1, 2026 (available to Washington applicants from July 2, 2026). MPJE passing scores obtained earlier remain acceptable prior evidence.
Return to active status of a Washington pharmacist license expired for three years or more without active practice in another U.S. jurisdiction

All of the following:

Expired Three Years Or More
The Washington pharmacist license has been expired for three years or more and the pharmacist has not been in active practice in another U.S. jurisdiction (WAC 246-945-173(3)).
General Requirements
Meets WAC 246-12-040 (WAC 246-945-173(3)(a)).
Internship
Serve an internship of 300 hours in compliance with WAC 246-945-163 (WAC 246-945-173(3)(b)).
Jurisprudence Transition
Guidance G010: MPJE passing scores are accepted only if the MPJE was taken on or before December 29, 2026; UMPJE passing scores are accepted if the UMPJE was taken on or after April 1, 2026 (available to Washington applicants from July 2, 2026). MPJE passing scores obtained earlier remain acceptable prior evidence.
Return to active status of a Washington pharmacist license expired for less than three years
No examination is required for this applicant pathway.
Expired Under Three Years
The license has been expired for less than three years (WAC 246-945-173(1)).
Requirements
Fees and declarations of WAC 246-12-040(3)(a) or (b) and 15 CPE hours per year the license has been expired (WAC 246-945-173(1)).

Official no-examination sources

Effective from 2026-06-14.

Return to active status of a Washington pharmacist license inactive for more than three years while actively practicing in another U.S. jurisdiction

At least one of the following alternatives:

  • Uniform MPJE
  • Multistate Pharmacy Jurisprudence Examination for Washington (practice unavailable)
Active Elsewhere
Provides certification of an active pharmacist license and verification of current active pharmacy practice from another U.S. jurisdiction (WAC 246-945-175(4)(a)-(b)).
General Requirements
Meets WAC 246-12-110 (written notice, current active renewal fee and declarations) (WAC 246-945-175(4)(c)).
Inactive More Than Three Years
The license has been inactive for more than three years and the pharmacist has been in active practice in another U.S. jurisdiction (WAC 246-945-175(4)).
Jurisprudence Transition
Guidance G010: MPJE passing scores are accepted only if the MPJE was taken on or before December 29, 2026; UMPJE passing scores are accepted if the UMPJE was taken on or after April 1, 2026 (available to Washington applicants from July 2, 2026). MPJE passing scores obtained earlier remain acceptable prior evidence.
Return to active status of a Washington pharmacist license inactive for more than three years without active practice in another U.S. jurisdiction

All of the following:

Inactive More Than Three Years
The license has been inactive for more than three years and the pharmacist has not been in active practice in another U.S. jurisdiction; WAC 246-945-173(3) applies (WAC 246-945-175(5)).
Internship
Serve an internship of 300 hours in compliance with WAC 246-945-163 (WAC 246-945-173(3)(b)).
Jurisprudence Transition
Guidance G010: MPJE passing scores are accepted only if the MPJE was taken on or before December 29, 2026; UMPJE passing scores are accepted if the UMPJE was taken on or after April 1, 2026 (available to Washington applicants from July 2, 2026). MPJE passing scores obtained earlier remain acceptable prior evidence.
Inactive pharmacist license for a Washington pharmacist leaving active practice in Washington
No examination is required for this applicant pathway.
Criteria
Holds an active Washington credential in good standing and will not practice in Washington; notifies the department in writing (WAC 246-12-090).

Official no-examination sources

Effective from 2024-06-13.

Return to active status of a Washington pharmacist license inactive for three years or less
No examination is required for this applicant pathway.
Inactive Up To Three Years
The license has been inactive for three years or less (WAC 246-945-175(3)).
Requirements
Written notice, current active renewal fee, declarations and continuing education for the two most recent years (WAC 246-12-110).

Official no-examination sources

Effective from 2026-06-14.

License by license transfer (reciprocity) for foreign graduate pharmacists licensed in another U.S. jurisdiction

All of the following:

Active License
Holds an active pharmacist license in good standing issued by another U.S. jurisdiction and files through NABP e-LTP (WAC 246-945-170(1)).
English Proficiency
Passing the required TOEFL iBT (Test of English as a Foreign Language, internet-based test) (WAC 246-945-162(2)(a)(ii)).
Foreign Education
Academic training in pharmacy from an institution in a foreign country; official transcripts or diploma showing a baccalaureate or doctorate of pharmacy degree (WAC 246-945-162(2)(b)); non-English documents must be translated.
Fpgec Certification
Certification by the Foreign Pharmacy Graduate Examination Committee (FPGEC), which includes passing the FPGEE and the required TOEFL iBT (WAC 246-945-162(2)(a)).
Internship
Certification of at least 1,500 pharmacy internship hours (WAC 246-945-162(2)(c)).
Jurisprudence Transition
Guidance G010: MPJE passing scores are accepted only if the MPJE was taken on or before December 29, 2026; UMPJE passing scores are accepted if the UMPJE was taken on or after April 1, 2026 (available to Washington applicants from July 2, 2026). MPJE passing scores obtained earlier remain acceptable prior evidence.
Nabp Transfer Note
NABP's UMPJE Participating States page lists Washington with 'UMPJE Required for Licensure Transfer: Yes'; the commission's own Guidance G010 and packet DOH 690-263 accept a passing MPJE (taken on or before December 29, 2026) or UMPJE (taken on or after April 1, 2026).
Passing Score
A score of 75 or higher on the jurisprudence examination (WAC 246-945-165(2)).
Reciprocal State Condition
RCW 18.64.080(5): the state of licensure must under similar conditions grant reciprocal licenses to pharmacists licensed by examination in Washington.
License by license transfer (reciprocity) for pharmacists licensed in another U.S. jurisdiction who graduated from an ACPE accredited U.S. program

At least one of the following alternatives:

  • Uniform MPJE
  • Multistate Pharmacy Jurisprudence Examination for Washington (practice unavailable)
Active License
Holds an active pharmacist license in good standing issued by another U.S. jurisdiction (WAC 246-945-170(1)); the transferred license need not be maintained after the Washington license is issued (Licensing Information page).
Education
Graduate of an accredited U.S. pharmacy school or college (DOH 690-263 item 1); evidence of the required secondary and professional education and training (RCW 18.64.080(5)).
Eltp
Files for license transfer through the NABP electronic license transfer program (e-LTP); the NABP application is valid for one year from receipt by the department (WAC 246-945-170(1)(a); Licensing Information page).
Jurisprudence Transition
Guidance G010: MPJE passing scores are accepted only if the MPJE was taken on or before December 29, 2026; UMPJE passing scores are accepted if the UMPJE was taken on or after April 1, 2026 (available to Washington applicants from July 2, 2026). MPJE passing scores obtained earlier remain acceptable prior evidence.
Nabp Transfer Note
NABP's UMPJE Participating States page lists Washington with 'UMPJE Required for Licensure Transfer: Yes'; the commission's own Guidance G010 and packet DOH 690-263 accept a passing MPJE (taken on or before December 29, 2026) or UMPJE (taken on or after April 1, 2026).
Passing Score
A score of 75 or higher on the jurisprudence examination (WAC 246-945-165(2)).
Reciprocal State Condition
RCW 18.64.080(5): the state of licensure must under similar conditions grant reciprocal licenses to pharmacists licensed by examination in Washington; pharmacists licensed by examination elsewhere before June 13, 1963 satisfy only the requirements in effect in Washington when they were licensed.
License portability for servicemembers and spouses relocating to Washington on military orders (50 U.S.C. 4025a)
No examination is required for this applicant pathway.
Covered License
Servicemember or spouse holding an active pharmacist license in good standing in another state, not revoked, disciplined, under pending investigation or surrendered under investigation (50 U.S.C. 4025a(f)(1); DOH 690-387).
Military Orders
Relocation because of military orders to Washington; copy of orders and, for a spouse, marriage certificate or registered domestic partnership document (50 U.S.C. 4025a(c); DOH 690-387).
Other State License
Unless the applicant obtains a Washington license, the other states' licenses must be maintained in good standing to continue practicing in Washington (DOH 690-388).

Official no-examination sources

Effective from 2024-12-23.

Renewal of an active Washington pharmacist license
No examination is required for this applicant pathway.
Continuing Education
30 hours of ACPE-accredited continuing education per renewal cycle, one-time suicide screening and referral training, and one hour of health equity training per cycle (WAC 246-945-178).
Cycle
Renew every two years on the credential holder's birthday (Licensing Information page).

Official no-examination sources

Effective from 2026-06-14.

Return to active status from retired active pharmacist license status
No examination is required for this applicant pathway.
Requirements
Written notice, current active renewal fee, declarations and continuing education (WAC 246-12-140) and the active renewal fee set in WAC 246-945-990 (WAC 246-945-171(5)).

Official no-examination sources

Effective from 2026-06-14.

Retired active pharmacist license status for a pharmacist holding an active Washington license
No examination is required for this applicant pathway.
Active License
Holds an active Washington pharmacist license in good standing, applies on the commission form and pays the retired credential status application fee (WAC 246-945-171(1)).
Practice Limit
Practice only in emergent or intermittent circumstances (no more than 90 days each year in Washington) and meet continuing education requirements (WAC 246-945-171(2)-(3)).

Official no-examination sources

Effective from 2023-04-09.

Original license by NAPLEX score transfer for graduates of a foreign school or college of pharmacy

All of the following:

English Proficiency
Passing the required TOEFL iBT (Test of English as a Foreign Language, internet-based test) (WAC 246-945-162(2)(a)(ii)).
Foreign Education
Academic training in pharmacy from an institution in a foreign country; official transcripts or diploma showing a baccalaureate or doctorate of pharmacy degree (WAC 246-945-162(2)(b)); non-English documents must be translated.
Fpgec Certification
Certification by the Foreign Pharmacy Graduate Examination Committee (FPGEC), which includes passing the FPGEE and the required TOEFL iBT (WAC 246-945-162(2)(a)).
Internship
Certification of at least 1,500 pharmacy internship hours earned in a licensed U.S. pharmacy (WAC 246-945-162(2)(c)).
Jurisprudence Transition
Guidance G010: MPJE passing scores are accepted only if the MPJE was taken on or before December 29, 2026; UMPJE passing scores are accepted if the UMPJE was taken on or after April 1, 2026 (available to Washington applicants from July 2, 2026). MPJE passing scores obtained earlier remain acceptable prior evidence.
Naplex Taken Elsewhere
The NAPLEX is taken in another state for score transfer to Washington; the same documentation, fees, intern hours and reports are required, and licensing requirements must be completed within one year from the date the commission receives the score transfer notification (DOH 690-264 item 4; WAC 246-945-165(4)).
Passing Score
A score of 75 or higher on the NAPLEX and the jurisprudence examination (WAC 246-945-165(2)).
Original license by NAPLEX score transfer for graduates of an ACPE accredited U.S. school or college of pharmacy

All of the following:

Jurisprudence Transition
Guidance G010: MPJE passing scores are accepted only if the MPJE was taken on or before December 29, 2026; UMPJE passing scores are accepted if the UMPJE was taken on or after April 1, 2026 (available to Washington applicants from July 2, 2026). MPJE passing scores obtained earlier remain acceptable prior evidence.
Naplex Taken Elsewhere
The NAPLEX is taken in another state and the score transferred to Washington; the NAPLEX score transfer must be requested from NABP within 89 days of taking the NAPLEX (Licensing Information page).
Other Qualifications
Same age, character, education and internship requirements as licensure by examination (RCW 18.64.080(1); WAC 246-945-162(1)).
Passing Score
A score of 75 or higher on each examination (WAC 246-945-165(2)).
Score Transfer Window
Licensing requirements must be completed within one year from the date the commission receives the score transfer notification (WAC 246-945-165(4)(b); DOH 690-236).

Pharmacist Temporary Practice Permit

Temporary practice permit for an applicant for a pharmacist license by license transfer while the fingerprint-based national background check is pending (RCW 18.130.075, WAC 246-945-170(2)).

Licensing authority: Washington State Pharmacy Quality Assurance Commission (Washington State Department of Health) · Application information

Temporary practice permit for a pharmacist license by license transfer applicant pending the background check

At least one of the following alternatives:

  • Uniform MPJE
  • Multistate Pharmacy Jurisprudence Examination for Washington (practice unavailable)
Background Check Pending
The fingerprint-based national background check results are pending (WAC 246-945-170(2)(c)).
Duration
Expires when the license is issued, when a notice of decision is mailed, or 180 days after issuance, with one 180-day extension possible; the holder cannot be a responsible pharmacy manager (WAC 246-945-170(3)-(4)).
Jurisprudence Transition
Guidance G010: MPJE passing scores are accepted only if the MPJE was taken on or before December 29, 2026; UMPJE passing scores are accepted if the UMPJE was taken on or after April 1, 2026 (available to Washington applicants from July 2, 2026). MPJE passing scores obtained earlier remain acceptable prior evidence.
License Transfer Applicant
Applicant for a pharmacist license by license transfer who meets all requirements and qualifications of WAC 246-945-170(1), including passing the approved jurisprudence examination (WAC 246-945-170(2)).
Request
Written request and payment of the temporary permit fee ($100 per WAC 246-945-990) (WAC 246-945-170(2)(d)).
Standing
Not subject to denial of a credential or issuance of a conditional or restricted credential in any U.S. jurisdiction, and no criminal record in Washington (WAC 246-945-170(2)(a)-(b)).

Foreign Pharmacy Graduate Equivalency Examination

Provider
National Association of Boards of Pharmacy
Format
Computerized fixed form
Exam questions
200 questions
Time limit
4.5 hours examination time; 5.5 hours total seat time
Passing score
Scaled score of 75
Examination outline
  • Foundational Biomedical Sciences (12%)
    • Anatomy and physiology
    • Biochemistry
    • Medical microbiology
    • Immunology
    • Pathophysiological bases of diseases
  • Pharmaceutical Sciences (31%)
    • Pharmaceutical calculations (eg, dose adjustments, delivery, ionization, ionic strength, isotonicity, ratio/percentage strength, osmolarity)
    • Medicinal chemistry
    • Medicinal chemistry: Physicochemical properties of drugs in relation to drug absorption, distribution, metabolism, and excretion (ADME)
    • Medicinal chemistry: Pathways of drug metabolism
    • Medicinal chemistry: Chemical bases for drug action, including bioorganic chemistry, structure-activity relationships, and fundamental pharmacophores related to drug-receptor interactions
    • Medicinal chemistry: Applicability to making drug therapy decisions
    • Pharmacology and toxicology
    • Pharmacology and toxicology: Pharmacodynamics, including drug-receptor interactions, agonists, antagonists, inverse agonists, and dose-response curves
    • Pharmacology and toxicology: Mechanisms of action of drugs, including biologics
    • Pharmacology and toxicology: Adverse effects and side effects of drugs
    • Pharmacology and toxicology: Mechanisms of drug interactions, including drug-drug, drug-disease, drug-food, drug-allergy, and drug-laboratory interactions
    • Pharmacology and toxicology: Mechanisms of acute and chronic toxic effects of xenobiotics, including drug and chemical overdose or exposure and antidotes
    • Pharmaceutics and biopharmaceutics
    • Pharmaceutics and biopharmaceutics: Dosage form development and drug delivery systems such as immediate release, sustained release, and controlled release
    • Pharmaceutics and biopharmaceutics: Disintegration and dissolution of solid oral dosage forms
    • Pharmaceutics and biopharmaceutics: Physicochemical properties of drugs, excipients, solutions, and dosage forms
    • Pharmaceutics and biopharmaceutics: Physical stability, chemical stability, and shelf-lives, including zero-, first-, second-, and pseudo-order reactions
    • Pharmaceutics and biopharmaceutics: Interactions between drug formulation and biological effects
    • Pharmaceutics and biopharmaceutics: Drug product manufacturing, including methods, processing, and quality assurance
    • Pharmacokinetics
    • Pharmacokinetics: Determining rates of absorption, distribution, metabolism, and excretion (ADME) of drugs
    • Pharmacokinetics: Factors affecting rates of ADME, including age, sex, genetics, diet, disease, and drug interactions
    • Pharmacokinetics: Biological half-lives of drugs and related dosing
    • Pharmacokinetics: Compartment models (one-, two-, and non-)
    • Pharmacokinetics: Linear and nonlinear pharmacokinetics
    • Pharmacokinetics: Principles of bioavailability, bioequivalence, and biosimilars
    • Pharmacogenomics (eg, population-based genetic influences on drug metabolism and efficacy, genetic testing, tumor genotyping, pharmacogenetic screening)
    • Extemporaneous compounding (eg, United States Pharmacopeia (USP) standards including Chapters <795>, <797>, and <800>; dosage form preparation calculations; techniques used to prepare and dispense sterile and nonsterile preparations)
  • Social, Behavioral, and Administrative Sciences (20%)
    • Pharmacy law and ethics
    • Pharmacy law and ethics: Laws and regulations governing pharmacy
    • Pharmacy law and ethics: Regulatory, oversight, and professional organizations
    • Pharmacy law and ethics: Principles and application of biomedical ethics
    • Health care systems
    • Health care systems: Organization, regulation, and financing of health care delivery in the United States
    • Health care systems: Factors that influence delivery and use of health care (eg, social, political, economic, and technological)
    • Pharmacoeconomics (eg, analysis, interpretation, application, humanistic outcomes)
    • Population-based care, pharmacoepidemiology, and public health
    • Population-based care, pharmacoepidemiology, and public health: Data sources and analytic tools
    • Population-based care, pharmacoepidemiology, and public health: Application of epidemiological study design
    • Population-based care, pharmacoepidemiology, and public health: Health promotion, disease prevention, and infection control
    • Population-based care, pharmacoepidemiology, and public health: Continuous quality improvement
    • Population-based care, pharmacoepidemiology, and public health: Social determinants and drivers of health
    • Practice management
    • Practice management: Financial management and budgeting
    • Practice management: Personnel management
    • Practice management: Business and strategic planning
    • Practice management: Risk management
    • Practice management: Procurement and inventory control
    • Professional communication
    • Professional communication: Verbal, nonverbal, written, and technology-based communication with patients, caregivers, providers, and stakeholders
    • Professional communication: Health literacy
    • Biostatistics and research methods (eg, study design, statistical tests, data collection instruments, research ethics)
    • Social and behavioral aspects of practice
    • Social and behavioral aspects of practice: Patient behavior including health-, illness-, and sick-role
    • Social and behavioral aspects of practice: Principles of behavior modification
    • Social and behavioral aspects of practice: Patient adherence
    • Social and behavioral aspects of practice: Cultural awareness
  • Pharmacy Practice and Clinical Sciences (37%)
    • Clinical pathophysiology as it applies to treatment of disease processes
    • Data collection (eg, patient history, physical assessments, laboratory values, point-of-care testing)
    • Data assessment (eg, clinical calculations, interpretation of data, diagnosing)
    • Patient-care decision making, therapy recommendations, and education (eg, plan, implement, monitor, follow-up)
    • Patient safety (eg, drug interactions, toxicity, drug-induced disease, drug use disorders)
    • Disease prevention (eg, screenings, immunization, non-pharmacological therapies, lifestyle modifications)
    • Personalized medicine (eg, pharmacokinetics, pharmacogenetics)
    • Evidence-based practice
    • Evidence-based practice: Practice guidelines
    • Evidence-based practice: Drug information and evaluation
    • Evidence-based practice: Information source reliability
    • Evidence-based practice: Clinical trial evaluation
    • Self-care, including using natural products
Examination sources

North American Pharmacist Licensure Examination

Provider
National Association of Boards of Pharmacy
Format
Computerized fixed form
Exam questions
225 questions
Time limit
6 hours
Passing score
Pass or Fail
Examination outline
  • Foundational Knowledge for Pharmacy Practice (25%)
    • Pharmaceutical science principles and concepts
    • Pharmaceutical science principles and concepts: Pharmacology
    • Pharmaceutical science principles and concepts: Pharmacokinetics, pharmacodynamics, or pharmacogenomics
    • Pharmaceutical science principles and concepts: Pharmaceutics
    • Pharmaceutical compounding
    • Pharmaceutical compounding: Nonsterile preparations
    • Pharmaceutical compounding: Sterile preparations
    • Pharmaceutical calculations
    • Pharmaceutical calculations: Patient parameters or laboratory measures
    • Pharmaceutical calculations: Quantities of drugs to be dispensed or administered
    • Pharmaceutical calculations: Rates of administration
    • Pharmaceutical calculations: Dose conversions
    • Pharmaceutical calculations: Drug concentrations, ratio strengths, osmolarity, or osmolality
    • Pharmaceutical calculations: Quantities of drugs or ingredients to be compounded
    • Pharmaceutical calculations: Nutritional needs and the content of nutrient sources
    • Pharmaceutical calculations: Biostatistical, epidemiological, or pharmacoeconomic measures
    • Pharmaceutical calculations: Pharmacokinetic parameters
    • Drug development processes (eg, clinical trial phases, emergency use authorizations)
    • Research design principles and biostatistics (eg, blinding, randomization, biases, statistical tests and outcomes, ethics)
    • Retrieval, assessment, and interpretation of primary, secondary, and tertiary resources
  • Medication Use Process (Prescribing, Transcribing and Documenting, Dispensing, Administering, and Monitoring) (25%)
    • Prescriptions and medication order interpretation
    • Prescriptions and medication order interpretation: Drug names and therapeutic classes
    • Prescriptions and medication order interpretation: Indications, usage, and dosing regimens
    • Prescriptions and medication order interpretation: Available dosage forms
    • Prescriptions and medication order interpretation: Prescription regulations (eg, boxed warnings, risk evaluation and mitigation strategies)
    • Prescriptions and medication order interpretation: Safety and effectiveness (eg, laboratory parameters, vital signs)
    • Therapeutic substitutions (eg, formulary restrictions, therapeutic alternatives, shortages, biosimilars)
    • Immunization services and documentation
    • Immunization services and documentation: Indications and scheduling
    • Immunization services and documentation: Contraindications and precautions
    • Immunization services and documentation: Storage and handling
    • Immunization services and documentation: Administration (eg, techniques, preparation, routes)
    • Immunization services and documentation: Adverse reactions
    • Medication handling, storage, stability, and disposal (eg, hazardous and nonhazardous drugs, controlled substances, parenteral medications, sharps handling, temperature control)
  • Person-Centered Assessment and Treatment Planning (40%)
    • Medication history, allergy history, and reconciliation
    • Health histories, screenings, and assessments
    • Patient health conditions, including special populations and medication-related factors
    • Patient health conditions, including special populations and medication-related factors: Signs, symptoms, and findings of medical conditions, etiology of diseases, or pathophysiology
    • Patient health conditions, including special populations and medication-related factors: Appropriateness of therapy (eg, medications, immunizations, non-drug therapy, dosing, contraindications, warnings, evidence-based decision making)
    • Patient health conditions, including special populations and medication-related factors: Interactions (eg, drug-drug, drug-condition, drug-food, drug-allergy, drug-laboratory)
    • Patient health conditions, including special populations and medication-related factors: Errors and omissions (eg, dosing, duplication, additional therapy needed, unnecessary therapy)
    • Patient health conditions, including special populations and medication-related factors: Adverse drug reactions
    • Patient health conditions, including special populations and medication-related factors: Toxicologic exposures and overdoses
    • Patient health conditions, including special populations and medication-related factors: Adherence
    • Therapeutic monitoring, plan development, evaluation, and modifications
    • Therapeutic monitoring, plan development, evaluation, and modifications: Therapeutic goals, clinical endpoints, and follow-up
    • Therapeutic monitoring, plan development, evaluation, and modifications: Safety
    • Therapeutic monitoring, plan development, evaluation, and modifications: Effectiveness
    • Patient education
    • Patient education: Lifestyle modifications and health maintenance
    • Patient education: Medication use, storage, and disposal
    • Patient education: Disease state management
    • Over-the-counter medications and dietary supplements
    • Devices to administer medications and self-monitoring tests
  • Professional Practice (5%)
    • Adverse drug event reporting and medication error reporting (eg, MedWatch, VAERS)
    • Public health initiatives and risk-prevention programs (eg, tobacco and nicotine cessation, antimicrobial stewardship, health screenings, opioid stewardship)
    • Social determinants and drivers of health
    • Ethical considerations (eg, informed consent, ethical principles, professional conduct and responsibility, patient confidentiality)
  • Pharmacy Management and Leadership (5%)
    • Pharmacy operations (eg, operational planning, risk management, regulations and regulatory bodies, technology applications and informatics, error-prevention strategies, medication safety)
    • Inventory and supply management (eg, drug recalls, drug shortages)
    • Quality improvement activities (eg, medication use evaluation, root-cause analysis, continuous quality improvement)
    • Mentorship and preceptorship (eg, providing and receiving feedback, delegation of work activities, preceptor roles)
Examination sources

Uniform MPJE

Provider
National Association of Boards of Pharmacy
Format
Computer-based adaptive selected-response examination
Exam questions
120 questions
Time limit
2.5 hours
Passing score
Pass or Fail
Examination outline
  • Pharmacy and Pharmacist Practice (30%)
    • Practice of pharmacy definition (eg, scope of authority, scope of practice, collaborative practice agreements and other delegative authorities, limitations or restrictions on practice)
    • Non-pharmacist personnel (eg, supervision, scope, licensure, counseling)
    • Adulterated or misbranded medications (eg, medication recalls, expiration dates, counterfeit medications, emergency use authorizations, importation, Drug Supply Chain Security Act (DSCSA))
    • Federal regulatory standards (eg, National Institute for Occupational Safety and Health (NIOSH), Occupational Safety and Health Administration (OSHA), essential copies of commercial products, patient-specific prescription requirements, anticipatory compounding)
    • United States Pharmacopeia (USP) standards on compounding and hazardous materials (eg, beyond-use dating, competency training, environmental testing, record keeping)
    • Security of patient health information
  • Medication Use Process (Prescribing, Transcribing and Documenting, Dispensing, Administering, and Monitoring) (30%)
    • Requirements for issuing prescriptions and medication orders, including controlled substances
    • Requirements for issuing prescriptions and medication orders, including controlled substances: Validity of a prescription (eg, authority, content, corresponding responsibility)
    • Requirements for issuing prescriptions and medication orders, including controlled substances: Changes to a prescription
    • Requirements for issuing prescriptions and medication orders, including controlled substances: Emergency prescriptions and emergency refills
    • Dispensing medications, including controlled substances
    • Dispensing medications, including controlled substances: Pharmacy and manufacturer labeling, including over-the-counter medications and patient education
    • Dispensing medications, including controlled substances: Drug utilization review
    • Dispensing medications, including controlled substances: Fills, refills, and partial fills
    • Dispensing medications, including controlled substances: Packaging and repackaging
    • Dispensing medications, including controlled substances: Counseling
    • Dispensing medications, including controlled substances: Transfers
    • Dispensing medications, including controlled substances: Prescription drug monitoring program (PDMP) requirements
    • Dispensing medications, including controlled substances: Recalls, returns, and reuse
    • Dispensing medications, including controlled substances: Drug product selection (eg, substitutions, interchangeability)
    • Administration of medications, including adverse event reporting
  • Regulatory Authority and Legal Obligations (20%)
    • Role of regulatory authorities, including authority, inspections, and discipline
    • Role of regulatory authorities, including authority, inspections, and discipline: Federal (eg, Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), US Department of Health and Human Services (HHS))
    • Role of regulatory authorities, including authority, inspections, and discipline: State (eg, board of pharmacy, department of health)
    • Controlled substances
    • Controlled substances: Inventory
    • Controlled substances: Record keeping
    • Controlled substances: Order forms and ordering
    • Controlled substances: DEA registration and power of attorney
    • Controlled substances: Theft and loss
    • Controlled substances: Disposal
    • Liability and malpractice
  • Pharmacy Operations (20%)
    • Licensures, registrations, and certifications
    • Pharmacy technology, including record keeping and automation (eg, e-prescribing, faxing, shared services)
    • Access, storage, handling, and security
Examination sources

Multistate Pharmacy Jurisprudence Examination for Washington

Provider
National Association of Boards of Pharmacy (NABP)
Format
Fixed-length computer adaptive test with multiple-choice and multiple-response items covering federal and Washington law
Passing score
75 (WAC 246-945-165(2))
Examination outline
  • Area 1 - Licensure/Personnel (22%)
    • 1.1 - Responsibilities of the pharmacist and non-pharmacist personnel
    • Qualifications, scope of duties, limitations, and restrictions of duties, or conditions to practice for pharmacists-in-charge (or equivalent) and pharmacists
    • Qualifications, scope of duties, limitations, and restrictions of duties, or conditions to practice for non-pharmacist personnel
    • 1.2 - Licensures, registrations, and certifications for pharmacists or non-pharmacist personnel
    • Qualifications, examinations, internships, maintaining pharmacist competency, and renewals of licensures, registrations, or certifications
    • Classifications and processes of disciplinary actions
    • Reporting to and participating in programs addressing the inability to practice with reasonable skill and safety
  • Area 2 - Pharmacist Practice (33%)
    • 2.1 - Requirements for issuing prescriptions/drug orders
    • Requirements for drug uses, limitations, or restrictions
    • Scope of authority, scope of practice, limitations or restrictions of practice, and valid registration of practitioners who are authorized to prescribe, dispense, or administer drugs
    • Requirements for issuing non-controlled prescriptions/drug orders
    • Requirements for issuing controlled prescriptions/drug orders
    • Authority limitations of practitioners’ ability to authorize refills
    • 2.2 - Conditions under which the pharmacist or non-pharmacist personnel participates in the administration of drugs in the management of patients’ therapy
    • 2.3 - Requirements regarding counseling
    • Counseling or offering to counsel
    • Documenting counseling or documenting offering to counsel
    • 2.4 - Returning or reusing drugs
    • 2.5 - Regulations and agencies regarding pharmacy practice
    • Requirements for promoting quality and safety of public health
    • Protecting patient and health record confidentiality
  • Area 3 - Dispensing Requirements (24%)
    • 3.1 - Responsibilities for determining whether prescriptions/drug orders are issued for a legitimate medical purpose, and within all applicable restrictions
    • 3.2 - Transferring prescription/drug order information between pharmacies by authorized personnel
    • 3.3 - Prospective drug utilization reviews
    • Requirements for reporting to PMP and accessing PMP data
    • 3.4 - Exceptions to dispensing or refilling prescriptions/drug orders
    • 3.5 - Labeling of dispensed drugs
    • 3.6 - Packaging of dispensed drugs
    • 3.7 - Drug product conditions prohibiting dispensing
    • 3.8 - Requirements for the distribution and/or dispensing of non-prescription pharmaceutical products, including controlled substances and hazardous drugs
    • Dispensing or administration
    • Labeling of non-prescription drugs and devices
    • Packaging and repackaging of non-prescription drugs and behind-the-counter products
    • Dispensing-restricted, non-prescription drugs
  • Area 4 - Pharmacy Operations (21%)
    • 4.1 - Ordering, acquisition, and distribution of drugs, including maintenance and content of such records
    • Ordering and acquisition, including the maintenance and content of such records
    • Distribution, including the maintenance and content of such records
    • 4.2 - Recordkeeping in compliance with legal requirements, including content, inventory, maintenance, storage, handling, and reporting
    • Non-dispensing requirements for operations of pharmacies or practice settings
    • Possession, storage, and handling of non-hazardous drugs
    • Training, possession, handling, storage, and disposal of hazardous drugs
    • Allowing non-pharmacist personnel access to drugs
    • Requirements for conducting controlled substance inventories
    • 4.3 - Delivery of drugs
    • 4.4 - Conditions for permitted or mandated product selection
    • 4.5 - Compounding sterile, nonsterile, hazardous, and non-hazardous preparations
    • 4.6 - Centralized prescription processing or central-fill pharmacy dispensing
    • 4.7 - Requirements for the registration, licensure, certification, or permitting of a practice setting or business entity
    • Requirements for registration, license, certification, or permitting of a practice setting
    • Requirements for the renewal or reinstatement of a license, registration, certificate, or permit of a practice setting
    • Requirements for an inspection of a licensed, registered, certified, or permitted practice setting
    • Classifications and processes of disciplinary actions that may be taken against a registered, licensed, certified, or permitted practice setting
Examination sources